Repligen's earnings call presented a strong performance with significant growth in non-COVID areas, particularly in biopharma and chromatography. Despite challenges from the gene therapy platform and muted biotech orders, the company's overall financial health, strategic initiatives, and increased guidance portray a positive outlook.

Company Guidance -

Q3 2025

During the earnings call, Repligen provided financial guidance for the full year 2025, emphasizing strong organic growth and operational performance. The company reported a 17% organic non-COVID growth in Q2 2025, marking the highest growth rate since 2022. Biopharma revenues grew by 20%, with orders increasing over 20% year-over-year. The revenue guidance for 2025 was raised to $715 million to $735 million, reflecting 12.5% to 15.5% organic non-COVID growth. Additionally, adjusted gross margins are expected to be in the range of 52% to 53%, with operating margins projected to be between 13.5% and 14.5%. Repligen also expects adjusted diluted earnings per share to be between $1.65 and $1.72, reflecting a 5% to 9% growth compared to the previous year. The company remains focused on strategic investments and operational efficiency to deliver above-market growth.

Strong Organic Non-COVID Growth

Repligen reported 17% organic non-COVID growth in Q2 2025, marking their highest growth rate since 2022. This growth was driven by strong performances across various segments such as Chromatography and Filtration.

Biopharma and CDMO Revenue Surge

Biopharma revenues grew 20% year-over-year, with orders also growing over 20%. CDMO revenues saw meaningful increases, with orders growing double digits.

Record Chromatography Revenue

Chromatography had a record quarter with greater than 40% revenue growth, driven by large-scale column demand from pharma in Europe.

Improved Guidance and Market Outlook

Repligen increased its 2025 revenue guidance to $715 million to $735 million, reflecting 12.5% to 15.5% organic non-COVID growth.

Strong Order Growth

Orders grew over 20% year-over-year and high teens organically, marking the eighth consecutive quarter of orders exceeding non-COVID revenue.

Sustainability Efforts Recognized

Repligen was named by Newsweek as one of the world's greenest companies in 2025, with a 25% reduction in waste generation last year.

Repligen (RGEN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RGEN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.42 / -	0.43	―	―	―
Jul 29, 2025	2025 (Q2)	0.39 / 0.37	0.33	12.12% (+0.04)	―
Apr 29, 2025	2025 (Q1)	0.35 / 0.39	0.28	39.29% (+0.11)	―
Feb 20, 2025	2024 (Q4)	0.41 / 0.44	0.33	33.33% (+0.11)	―
Nov 12, 2024	2024 (Q3)	0.34 / 0.43	0.23	86.96% (+0.20)	―
Jul 30, 2024	2024 (Q2)	0.33 / 0.33	0.53	-37.74% (-0.20)	―
May 01, 2024	2024 (Q1)	0.30 / 0.28	0.64	-56.25% (-0.36)	―
Feb 21, 2024	2023 (Q4)	0.33 / 0.33	0.68	-51.47% (-0.35)	―
Oct 31, 2023	2023 (Q3)	0.17 / 0.23	0.77	-70.13% (-0.54)	―
Aug 02, 2023	2023 (Q2)	0.47 / 0.53	0.91	-41.76% (-0.38)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RGEN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 29, 2025	$119.65	$125.30	+4.72%
Apr 29, 2025	$143.63	$139.43	-2.92%
Feb 20, 2025	$150.73	$162.67	+7.92%
Nov 12, 2024	$139.51	$148.59	+6.51%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Repligen Corp (RGEN) report earnings?

Repligen Corp (RGEN) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).

What is Repligen Corp (RGEN) earnings time?

Repligen Corp (RGEN) earnings time is at Nov 04, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RGEN EPS forecast?

RGEN EPS forecast for the fiscal quarter 2025 (Q3) is 0.42.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing